(VIANEWS) – Kimco Realty Corporation (KIM), Main Street Capital Corporation (MAIN), Bristol (BMY) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio as yet. The payout ratio in itself isn’t a promise of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. Kimco Realty Corporation (KIM)
525% Payout Ratio
Kimco Realty Corp. (NYSE:KIM) is a real estate investment trust (REIT) headquartered in Jericho, N.Y. that is one of North America's largest publicly traded owners and operators of open-air, grocery-anchored shopping centers and mixed-use assets. As of June 30, 2020, the company owned interests in 400 U.S. shopping centers and mixed-use assets comprising 70 million square feet of gross leasable space primarily concentrated in the top major metropolitan markets. Publicly traded on the NYSE since 1991, and included in the S&P 500 Index, the company has specialized in shopping center acquisitions, development and management for more than 60 years.
Earnings Per Share
As for profitability, Kimco Realty Corporation has a trailing twelve months EPS of $0.16.
PE Ratio
Kimco Realty Corporation has a trailing twelve months price to earnings ratio of 115.69. Meaning, the purchaser of the share is investing $115.69 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.15%.
Yearly Top and Bottom Value
Kimco Realty Corporation’s stock is valued at $18.51 at 14:23 EST, way under its 52-week high of $26.57 and above its 52-week low of $17.34.
Revenue Growth
Year-on-year quarterly revenue growth grew by 3.6%, now sitting on 1.73B for the twelve trailing months.
2. Main Street Capital Corporation (MAIN)
81.03% Payout Ratio
Main Street Capital Corporation is a principal investment firm that primarily provides equity capital to lower middle market companies and debt capital to middle market companies. Main Street's portfolio investments are typically made to support management buyouts, recapitalizations, growth financings, refinancings and acquisitions of companies that operate in diverse industry sectors. Main Street seeks to partner with entrepreneurs, business owners and management teams and generally provides "one stop" financing alternatives within its lower middle market portfolio. Main Street's lower middle market companies generally have annual revenues between $10 million and $150 million. Main Street's middle market debt investments are made in businesses that are generally larger in size than its lower middle market portfolio companies.
Earnings Per Share
As for profitability, Main Street Capital Corporation has a trailing twelve months EPS of $0.45.
PE Ratio
Main Street Capital Corporation has a trailing twelve months price to earnings ratio of 88.28. Meaning, the purchaser of the share is investing $88.28 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.54%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Mar 6, 2023, the estimated forward annual dividend rate is 2.7 and the estimated forward annual dividend yield is 6.89%.
Moving Average
Main Street Capital Corporation’s value is below its 50-day moving average of $39.75 and higher than its 200-day moving average of $38.91.
3. Bristol (BMY)
74.24% Payout Ratio
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Abraxane, a protein-bound chemotherapy product; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; and Empliciti for the treatment of multiple myeloma. In addition, the company offers Zeposia to treat relapsing forms of multiple sclerosis; Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Inrebic, an oral kinase inhibitor indicated for the treatment of adult patients with myelofibrosis; and Onureg for the treatment of adult patients with AML. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, Bristol has a trailing twelve months EPS of $2.95.
PE Ratio
Bristol has a trailing twelve months price to earnings ratio of 23.98. Meaning, the purchaser of the share is investing $23.98 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.46%.
Sales Growth
Bristol’s sales growth is negative 1.1% for the current quarter and 0.7% for the next.
Previous days news about Bristol (BMY)
- Bristol myers' (bmy) breyanzi gets positive CHMP opinion. According to Zacks on Monday, 3 April, "Shares of Bristol Myers have lost 6.1% in the past year compared with the industry’s decline of 16.6%.", "Bristol Myers Squibb Company price-consensus-eps-surprise-chart | Bristol Myers Squibb Company Quote"
4. Fanhua (FANH)
55.23% Payout Ratio
Fanhua Inc., together with its subsidiary, distributes insurance products in China. It operates through two segments, Insurance Agency and Claims Adjusting. The Insurance Agency segment provides property and casualty insurance products that primarily include individual accident, travel, homeowner, and indemnity medical insurance products; and life insurance products, such as individual health, individual whole life, individual term life, individual endowment life, and individual annuity, as well as participating insurance products. The Claims Adjusting segment offers pre-underwriting survey, claims adjusting, residual value disposal, loading and unloading supervision, and consulting services. The company also operates baoxian.com, an online insurance platform, which allows customers to search for, and purchase a range of insurance products; Lan Zhanggui, an internet-based all-in-one application; and ehuzhu.com, an online non-profit mutual aid platform, as well as CNpad Auto for facilitating auto insurance transaction. It serves customers through insurance sales and service group, and insurance agencies, as well as sales and service branches and outlets, registered independent sales agents, and in-house claims adjustors. The company was formerly known as CNinsure Inc. and changed its name to Fanhua Inc. in December 2016. Fanhua Inc. was founded in 1998 and is headquartered in Guangzhou, China.
Earnings Per Share
As for profitability, Fanhua has a trailing twelve months EPS of $0.26.
PE Ratio
Fanhua has a trailing twelve months price to earnings ratio of 31.38. Meaning, the purchaser of the share is investing $31.38 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.64%.
5. Union Pacific Corporation (UNP)
45.32% Payout Ratio
Union Pacific Corporation, through its subsidiary, Union Pacific Railroad Company, operates in the railroad business in the United States. The company offers transportation services for grain and grain products, fertilizers, food and refrigerated products, and coal and renewables to grain processors, animal feeders, ethanol producers, and other agricultural users; petroleum, and liquid petroleum gases; and construction products, industrial chemicals, plastics, forest products, specialized products, metals and ores, soda ash, and sand, as well as finished automobiles, automotive parts, and merchandise in intermodal containers. As of December 31, 2021, its rail network included 32,452 route miles connecting Pacific Coast and Gulf Coast ports with the Midwest and Eastern United States gateways. The company was founded in 1862 and is headquartered in Omaha, Nebraska.
Earnings Per Share
As for profitability, Union Pacific Corporation has a trailing twelve months EPS of $7.73.
PE Ratio
Union Pacific Corporation has a trailing twelve months price to earnings ratio of 25.59. Meaning, the purchaser of the share is investing $25.59 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 53.17%.
6. JP Morgan Chase (JPM)
33.09% Payout Ratio
JPMorgan Chase & Co. operates as a financial services company worldwide. It operates through four segments: Consumer & Community Banking (CCB), Corporate & Investment Bank (CIB), Commercial Banking (CB), and Asset & Wealth Management (AWM). The CCB segment offers s deposit, investment and lending products, payments, and services to consumers; lending, deposit, and cash management and payment solutions to small businesses; mortgage origination and servicing activities; residential mortgages and home equity loans; and credit card, auto loan, and leasing services. The CIB segment provides investment banking products and services, including corporate strategy and structure advisory, and equity and debt markets capital-raising services, as well as loan origination and syndication; payments and cross-border financing; and cash and derivative instruments, risk management solutions, prime brokerage, and research. This segment also offers securities services, including custody, fund accounting and administration, and securities lending products for asset managers, insurance companies, and public and private investment funds. The CB segment provides financial solutions, including lending, payments, investment banking, and asset management to small business, large and midsized companies, local governments, and nonprofit clients; and commercial real estate banking services to investors, developers, and owners of multifamily, office, retail, industrial, and affordable housing properties. The AWM segment offers multi-asset investment management solutions in equities, fixed income, alternatives, and money market funds to institutional clients and retail investors; and retirement products and services, brokerage, custody, trusts and estates, loans, mortgages, deposits, and investment management products. The company also provides ATM, online and mobile, and telephone banking services. JPMorgan Chase & Co. was founded in 1799 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, JP Morgan Chase has a trailing twelve months EPS of $12.08.
PE Ratio
JP Morgan Chase has a trailing twelve months price to earnings ratio of 10.58. Meaning, the purchaser of the share is investing $10.58 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.85%.
Yearly Top and Bottom Value
JP Morgan Chase’s stock is valued at $127.76 at 14:23 EST, way under its 52-week high of $144.34 and way above its 52-week low of $101.28.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 30.8% and 18.5%, respectively.
